[PDF][PDF] Prospect of stem cell therapy to avoid cytokine storm in severe covid-19

JA Pawitan - International Journal of Applied …, 2020 - pdfs.semanticscholar.org
Severe COVID-19 cases are mostly due to severe inflammatory reaction and cytokine storm,
which may lead to multiple organ failure and death. Until recently, there is no proven …

Clinical consideration for mesenchymal stem cells in treatment of COVID-19

KH Wu, YH Chao, TF Weng, JP Li - Current Pharmaceutical …, 2022 - ingentaconnect.com
COVID-19, which has strongly affected the 21st century, is caused by severe acute
respiratory syndrome (SARS)-CoV-2. The emergence of viral variants has rendered even …

Research progress of mesenchymal stem cell therapy for severe COVID-19

Q Cai, F Yin, L Hao, W Jiang - Stem Cells and Development, 2021 - liebertpub.com
Corona virus disease 2019 (COVID-19) refers to a type of pneumonia caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Sixty million confirmed …

Mesenchymal stem cell infusion as a promising therapeutic approach to treat coronavirus disease 2019 patients

N AlMuraikhi - Journal of Nature and Science of Medicine, 2020 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious respiratory infection
that emerges as a serious healthcare problem and becomes a global pandemic. The …

Feasibility of mesenchymal stem cell therapy for COVID-19: a mini review

J Li, X Wang, N Li, Y Jiang, H Huang… - Current Gene …, 2020 - ingentaconnect.com
Patients infected with SARS-CoV-2 carry the coronavirus disease 2019 (COVID-19) which
involves multiple systems and organs with acute respiratory distress syndrome (ARDS) as …

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

S Sadeghi, S Soudi, A Shafiee, SM Hashemi - Life sciences, 2020 - Elsevier
The outbreak of COVID-19 in December 2019, has become an urgent and serious public
health emergency. At present, there is no effective treatment or vaccine for COVID-19 …

[HTML][HTML] The therapeutic potential of mesenchymal stem cells in COVID-19: Present and future

MI Sari, IB Putra, DW Wijaya - Research Results in Pharmacology, 2023 - cyberleninka.ru
Introduction: Coronavirus disease 2019 (COVID-19) was first reported in 2019 and has since
become a health concern due to its rapid spread and high mortality rate. With the discovery …

Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19

E Zendedel, L Tayebi, M Nikbakht… - Current Stem Cell …, 2024 - ingentaconnect.com
Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …

[HTML][HTML] Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials

W Lu, L Yan, X Tang, X Wang, J Du, Z Zou… - Journal of …, 2024 - ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) has become a serious public health
issue. In COVID-19 patients, the elevated levels of inflammatory cytokines lead to the …

MESENCHYMAL STEM CELL THERAPY FOR COVID-19: A LITERATURE REVIEW.

F Ufaira Prameswari… - Journal of Syntax …, 2022 - search.ebscohost.com
Abstract Coronavirus Disease (COVID-19), is an acute respiratory disease that has become
a health crisis that threatens the world. A treatment plan that can aim to reduce the number …